End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.037 AUD | +2.78% |
|
+5.71% | -9.76% |
02-22 | PharmX Technologies Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Sales 2022 | 11.95M 7.97M 628M | Sales 2023 | 6.13M 4.09M 322M | Capitalization | 22.1M 14.74M 1.16B |
---|---|---|---|---|---|
Net income 2022 | - 0 0 | Net income 2023 | -1M -667K -52.57M | EV / Sales 2022 | 1.24 x |
Net cash position 2022 | 5.43M 3.62M 286M | Net cash position 2023 | 12.77M 8.52M 672M | EV / Sales 2023 | 1.52 x |
P/E ratio 2022 |
85.2
x | P/E ratio 2023 |
-20.8
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 40.97% |
1 day | +2.78% | ||
1 week | +5.71% | ||
Current month | +37.04% | ||
1 month | +19.35% | ||
3 months | +23.33% | ||
6 months | -9.76% | ||
Current year | -9.76% |
![Extreme 0.032](/images/extremecours_fleche.png)
![Extreme 0.026](/images/extremecours_fleche.png)
![Extreme 0.012](/images/extremecours_fleche.png)
![Extreme 0.012](/images/extremecours_fleche.png)
![Extreme 0.012](/images/extremecours_fleche.png)
![Extreme 0.012](/images/extremecours_fleche.png)
![Extreme 0.012](/images/extremecours_fleche.png)
Date | Price | Change | Volume |
---|---|---|---|
19/06/24 | 0.037 | +2.78% | 389,935 |
18/06/24 | 0.036 | +9.09% | 511,840 |
17/06/24 | 0.033 | -5.71% | 578,205 |
14/06/24 | 0.035 | 0.00% | 483,774 |
12/06/24 | 0.035 | 0.00% | 46 |
End-of-day quote Australian S.E., June 18, 2024
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-9.76% | 14.77M | |
+32.02% | 460B | |
+40.83% | 295B | |
+14.23% | 147B | |
+8.19% | 93.51B | |
+64.92% | 61.46B | |
+14.18% | 46.17B | |
+21.32% | 36.97B | |
+19.38% | 30.21B | |
-16.78% | 29.71B |
- Stock Market
- Equities
- PHX Stock